The Latest Breaking News from FDA

Several medical and LGBTQ groups have called the FDA's blood donor restrictions on gay men "discriminatory."

The U.S. is making it easier for gay and bisexual men to give blood by easing restrictions on groups that traditionally face higher risks of HIV

At a meeting to simplify the nation’s COVID-19 vaccination policy, the FDA’s panel of experts could agree on only one thing: Information is woefully lacking about how often different groups of Americans need to be vaccinated. That data gap has contributed to widespread skepticism, undervaccination, and ultimately unnecessary deaths from…

Videos appearing to show people experiencing severe side effects after allegedly receiving COVID-19 vaccines are making the rounds on social media as part of a renewed push from anti-vaccine movements to cast doubt on safety.

The first significant stage of post-Roe abortion litigation is underway and focuses heavily on abortion pills. GenBioPro, a pharmaceutical company that makes the drug mifepristone, has asked a federal court to declare that West Virginia’s anti-abortion law is inconsistent with the Federal Drug Administration’s determination that the pill is safe…

The Food and Drug Administration (FDA) has suspended sales of a Korean instant noodles brand after Taiwan's Food and Drug Administration (TFDA) announced that pesticide residue was found in some packages.

Bivalent COVID-19 shot should become standard, FDA advisers say

Bivalent COVID-19 shots should become the standard form of the vaccine, U.S. advisers said, part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant strains.

The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot

The Food and Drug Administration on Thursday announced that CBD products, increasingly popular but largely unregulated, will soon join the ranks of other more mainstream, regulated products.

Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.